UV1 vaccine combination shows no significant PFS improvement in BRCA wild type recurrent ovarian cancer

HBI-8000 plus nivolumab significantly improves progression-free survival in advanced melanoma

Camupepimut shows early disease free survival signal in resected KRAS mutated pancreatic cancer

Neoadjuvant trastuzumab deruxtecan targets HER2-low breast cancer cells to assess tumour response before surgery

AI tool identifies patients most likely to benefit from extended endocrine therapy in hormone receptor-positive breast cancer

Extended letrozole improves disease-free survival in hormone receptor-positive breast cancer: 15-year results

Perioperative pembrolizumab fails to significantly improve event-free survival in muscle-invasive bladder cancer

Sacituzumab govitecan combination shows promising activity in first line metastatic urothelial cancer